These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10702391

  • 1. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.
    van Kempen LC, van den Oord JJ, van Muijen GN, Weidle UH, Bloemers HP, Swart GW.
    Am J Pathol; 2000 Mar; 156(3):769-74. PubMed ID: 10702391
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.
    van Kempen LC, Meier F, Egeblad M, Kersten-Niessen MJ, Garbe C, Weidle UH, Van Muijen GN, Herlyn M, Bloemers HP, Swart GW.
    J Invest Dermatol; 2004 May; 122(5):1293-301. PubMed ID: 15140234
    [Abstract] [Full Text] [Related]

  • 4. WT 1 expression in nevi and melanomas: a marker of melanocytic invasion into the dermis.
    Garrido-Ruiz MC, Rodriguez-Pinilla SM, Pérez-Gómez B, Rodriguez-Peralto JL.
    J Cutan Pathol; 2010 May; 37(5):542-8. PubMed ID: 19638168
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
    Donizy P, Zietek M, Halon A, Leskiewicz M, Kozyra C, Matkowski R.
    Diagn Pathol; 2015 Jul 02; 10():86. PubMed ID: 26134500
    [Abstract] [Full Text] [Related]

  • 6. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U, Kilian U, Henkel U, Schaarschmidt H, Knopf B.
    Anticancer Res; 1991 Jul 02; 11(4):1405-14. PubMed ID: 1746897
    [Abstract] [Full Text] [Related]

  • 7. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
    van Kilsdonk JW, Wilting RH, Bergers M, van Muijen GN, Schalkwijk J, van Kempen LC, Swart GW.
    Cancer Res; 2008 May 15; 68(10):3671-9. PubMed ID: 18483249
    [Abstract] [Full Text] [Related]

  • 8. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
    Gambichler T, Rotterdam S, Radkowski K, Altmeyer P, Kreuter A.
    Am J Clin Pathol; 2009 May 15; 131(5):710-4. PubMed ID: 19369632
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
    Jezierska A, Matysiak W, Motyl T.
    Med Sci Monit; 2006 Aug 15; 12(8):BR263-73. PubMed ID: 16865058
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. E-cadherin/catenin complex in benign and malignant melanocytic lesions.
    Silye R, Karayiannakis AJ, Syrigos KN, Poole S, van Noorden S, Batchelor W, Regele H, Sega W, Boesmueller H, Krausz T, Pignatelli M.
    J Pathol; 1998 Dec 15; 186(4):350-5. PubMed ID: 10209482
    [Abstract] [Full Text] [Related]

  • 13. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?
    Swart GW, Lunter PC, Kilsdonk JW, Kempen LC.
    Cancer Metastasis Rev; 2005 Jun 15; 24(2):223-36. PubMed ID: 15986133
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness.
    Bayer-Garner IB, Hough AJ, Smoller BR.
    Mod Pathol; 1999 Aug 15; 12(8):770-4. PubMed ID: 10463478
    [Abstract] [Full Text] [Related]

  • 16. Metallothionein-overexpression as a prognostic marker in melanoma.
    Weinlich G.
    G Ital Dermatol Venereol; 2009 Feb 15; 144(1):27-38. PubMed ID: 19218909
    [Abstract] [Full Text] [Related]

  • 17. Cell adhesion and communication proteins are differentially expressed in melanoma progression model.
    Rezze GG, Fregnani JH, Duprat J, Landman G.
    Hum Pathol; 2011 Mar 15; 42(3):409-18. PubMed ID: 21193224
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
    Cohn ML, Goncharuk VN, Diwan AH, Zhang PS, Shen SS, Prieto VG.
    J Cutan Pathol; 2005 Sep 15; 32(8):533-6. PubMed ID: 16115050
    [Abstract] [Full Text] [Related]

  • 20. Oestrogen receptor-beta expression in melanocytic lesions.
    Schmidt AN, Nanney LB, Boyd AS, King LE, Ellis DL.
    Exp Dermatol; 2006 Dec 15; 15(12):971-80. PubMed ID: 17083364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.